Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: A report from the children's oncology group

Mary C. Blandford, Frederic G. Barr, James C. Lynch, R. L. Randall, Stephen J. Qualman, Charles Keller

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: A report from the children's oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences